I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Impacting around 2.1 million females across the globe every year, breast cancer is considered to be the most frequently occurring cancers and also one of the leading causes of cancer-related deaths among the women according to the 2018 WHO reports.\[[@ref1]\]

Remarkable advancement in detection and treatment has led to a consequential rise in percentage of cancer survivors around the world. A 2017 study done in Korea by Shin *et al*. states that because of the treatment advances, the prognosis after the diagnosis of breast cancer has become better over the last few years and has brought the survival rate of the patients with breast cancer to up to 5 years postdiagnosis.\[[@ref2]\]

Although these treatments have increased the survival rates in the breast cancer survivors, at the same time their side effects have a major impact on the functioning of these patients. Anticancer treatments, namely chemotherapy or radiotherapy, result in a group of adverse effects which include fatigue, anxiety, depression, loss of appetite, impaired joint range of motion, exercise intolerance, and physical inactivity.\[[@ref3]\]

Of these, one of the major unaddressed and overlooked side effects of all the anticancer treatment is fatigue.\[[@ref4]\] Cancer-related fatigue is a distressing, persistent, subjective sense of tiredness or exhaustion related to cancer or its treatment that is not proportional to recent activity and interferes with usual functioning.\[[@ref5]\] Among all anticancer treatments, maximum patients (98.30%) undergoing chemotherapy report fatigue as their major concern when compared to other treatments (chemoradiotherapy - 78.57% and radiotherapy - 45%).\[[@ref4]\]

It is predicted that the consequences of physical inactivity such as diabetes and hypertension in the population experiencing a chronic disease are subjected to cost billions of dollars each year and are associated with mortality. However, exercises have so far shown positive results with regard to the side effects of physical inactivity, and to promote the same, pedometers have recently gained recognition as an intervention with physical activity.

Thus, this review is conducted to answer specific questions which are:

Does a pedometer when used in conjunction with exercises give any significant changes in cancer-related fatigue and overall quality of life for patients with breast cancer undergoing chemotherapy?What type of pedometer-based protocols is used in the studies which show a significant difference in overall fitness and health-related outcomes in patients with breast cancer undergoing chemotherapy?

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Search strategy and selection criteria {#sec2-1}
--------------------------------------

Studies were identified using a comprehensive search of PubMed, CINAHL, Embase, Scopus, Cochrane Library, and PEDro. The identification of the articles was done using the search terms pedometers; step count; steps; aerobic exercise; aerobic training; physical activity; physical inactivity; physical therapy; physiotherapy; breast cancer; breast carcinoma; breast tumor; chemotherapy; and Ca breast and breast neoplasm in conjunction with the Boolean operators "AND," "OR," and "NOT."

We included only randomized controlled trials (RCTs) in our review. The search was restricted to studies on humans and articles published in English language. Articles falling in the custom range of 2010--2019 are included in the review because the first study using a pedometer in breast cancer population was done in 2010.\[[@ref6]\] Initial searches were carried out in January--February 2019. Other consecutive searches were done in April 2019. Two investigators (AG and SRS) autonomously conducted the searches in the above-mentioned search engines. All the retrieved data were desegregated and individually screened for eligibility criteria by AG and SRS. Any differences in the opinion were resolved by discussions between AG and SRS, and if needed, through mediation by author KVK.

Quality assessment and methodological rating {#sec2-2}
--------------------------------------------

All the retrieved trials that were eligible for the systematic review were assessed for quality of study following which a methodological rating was given to each by authors AG and KVK using the Physiotherapy Evidence Database scale for RCTs.\[[@ref7]\] The scale has 11 components with a simple answering method through "yes" or "no." The maximum score rewarded is 10 as the first component is not scored.\[[@ref8]\] The scores were allotted by author AG and scrutinized by author KVK. Any differences in the opinion were resolved by discussions between AG and KVK, and if needed, through mediation by author SRS.

A data extraction sheet was made and revised to cover all the data regarding the objectives of the study, site and stage of cancer, type of exercise intervention, primary and secondary outcome measures, study design, sample size, participant selection, medical and surgical intervention, details of exercise intervention, and adverse events as reported by the study. Data were organized to highlight study characteristics, methodological rating score, site and stage of cancer, type of exercise interventions, and outcomes reported from each of the selected study.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

All the retrieved data, which summed up to 275 articles, were fed in Paul Foeckler, Victor Henning, Jan Reichelt. Elsevier copyright. London, UK. Mendeley Desktop v1.19.2. Duplicates were checked and merged. The articles were then screened through the titles, and around 54 articles were found eligible. Furthermore, through abstract reading, 210 articles were filtered out, following which full-text reading was done and 45 were excluded. Of those 165 articles, 3 articles were found eligible after screening for the inclusion and exclusion criteria formulated in the outline of the search review. The PRISMA flow diagram in [Figure 1](#F1){ref-type="fig"} summarizes the identification, screening, eligibility, and inclusion of the clinical trials.

![PRISMA flow diagram](IJPC-26-105-g001){#F1}

All the retrieved trials that were eligible for the systematic review underwent a quality rating following which a methodological rating was given to each using the PEDro scale for RCTs. The scores ranged from 7 to 10 of 11, and therefore, the trials were categorized as high quality (6--10). All the studies were reasonably reliable to assess the effect of intervention on their principle outcome measures. The total and element scores of PEDro scale are summarized in [Table 1](#T1){ref-type="table"}.

###### 

PEDro scores of the included trials

  Authors                     Components of PEDro scale   Maximum total score (10)                                                         
  --------------------------- --------------------------- -------------------------- ----- ----- ----- ----- ----- ----- ----- ----- ----- ------
  Djuric *et al*. (2011)      Yes                         Yes                        Yes   Yes   Yes   No    No    Yes   Yes   Yes   Yes   8/10
  Pelekasis *et al*. (2016)   Yes                         Yes                        No    Yes   Yes   No    No    Yes   No    Yes   Yes   6/10
  Gokal *et al*. (2018)       Yes                         Yes                        Yes   No    Yes   Yes   Yes   Yes   Yes   Yes   Yes   9/10

ITT: Intention-to-treat

All the trials had a homogeneous group of patients, that is, patients with breast cancer undergoing chemotherapy. Three distinct brackets of exercise interventions were noted which are home-based walking program, dietetic intervention, and psychological therapy. All the study-related details regarding the cancer site, study design, sample size, cancer management, type of exercise intervention, and outcome measures assessed are summarized in [Table 2](#T2){ref-type="table"}, whereas the detailed explanation of exercise protocols and their respective results are mentioned in [Table 3](#T3){ref-type="table"}.

###### 

Details of all the trials included in the review

  References                       Cancer site/stage           Study design   Sample size   Cancer management                       Exercise intervention                                                                           Outcome assessment
  -------------------------------- --------------------------- -------------- ------------- --------------------------------------- ----------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------
  Djuric *et al*.\[[@ref9]\]       Breast; I-IIIA              RCT            40            Chemotherapy                            Dietary management, tele-based motivational interviewing, pedometer-based walking               BMI, body fat percentage, waist circumference, weight, dietary fat intake, fatigue (FACT-G, FACT-B), total physical activity
  Pelekasis *et al*.\[[@ref10]\]   Breast cancer; Stage I-IV   RCT            61            Chemotherapy                            Pedometer-based walking (8300-10,000 steps), DB, PMR, dietary consulting, guided imagery, CBT   BMI, QoL (SRH, HLC), night sleep duration, sleep onset latency, DASS-21 score, and spiritual health (SWBS)
  Gokal *et al*.\[[@ref11]\]       Breast cancer               RCT            50            Adjuvant and neoadjuvant chemotherapy   Home-based walking program (150 min/week)                                                       Executive function (Stroop task), working memory (WAIS-III), attention (SART), and cognitive functioning (CFQ)

RCT: Randomized controlled trial, BMI: Body mass index, FACT-G: Functional Assessment of Cancer Treatment-General, FACT-B: Functional Assessment of Cancer Treatment-Breast, DB: Diaphragmatic breathing, PMR: Progressive muscle relaxation, CBT: Cognitive behavioral therapy, SRH: Self-reported health, HLC: Health locus of control, DASS-21: Depression Anxiety Stress Scale-21, SWBS: Spiritual Well-Being Scale, WAIS-III: Wechsler Adult Intelligence Scale-III, SART: Sustained Attention to Response Task, CFQ: Cognitive Failures Questionnaire, QoL: Quality of life

###### 

Details of exercise protocols and their respective results

  Author (year)                                                                          Exercise intervention                     Results                                              
  -------------------------------------------------------------------------------------- ----------------------------------------- ------------------------------------ --------------- ---------------
  Djuric *et al*. (2011)\[[@ref9]\]                                                      Intervention group                        Body fat (%)                         40.8±2.0        37.3±1.3
   Received written educational materials                                                Body lean (%)                             57.1±1.8                             60.1±1.3        
   Fruit and vegetable goals=8/day=1700-1900 kcal/day                                    Waist circumference                       93.4±3.7                             91.8±3.4        
   30 min/day of moderate to vigorous activity with pedometers                           Weight                                    72.0±4.2                             70.9±3.7        
   Permitted for dietary counseling                                                      BMI                                       26.9±1.3                             26.1±1.3        
  Control group                                                                          Dietary fat intake                        32.6±1.8                             26.9±2.2        
   "My Pyramid" written plan from the USDA                                               FACT-B                                    116±4                                116±5           
   Daily exercise (30 min/day)                                                           FACT-G                                    89±3                                 88±4            
   Dietary Guidelines for Americans 2005                                                 Total physical activity                   265±39                               364±55          
   No dietary or exercise counseling provided                                            Adverse events: None                                                                           
   Only telephone counseling                                                                                                                                                            
                                                                                                                                                                                        
  **Author (year)**                                                                      **Exercise intervention**                 **Results**                                          
                                                                                                                                                                                        
  **Outcome measure**                                                                    **Intervention group**                    **Control group**                                    
                                                                                                                                                                                        
  Pelekasis *et al*. (2016)\[[@ref10]\]                                                  Intervention group                        BMI                                  0.21±0.38       0.11±0.23
   8-week stress management and health promotion program                                 SRH                                       0.56±1.61                            0.25±1.55       
    1^st^ week - physical activity-walking at least                                      Night sleep duration                      0.89±0.89                            0.02±0.68       
    8300-10,000 steps/day                                                                Sleep onset latency                       12.12±16.6                           2.35±9.74       
    2^nd^ week - DB (practicing 2 times/day)                                             DASS-21 score                             12.16±10.15                          1.93±8.7        
    3^rd^ week - PMR (practicing twice a day)                                            HLC (internal)                            2.48±4.40                            0.39±4.00       
    4^th^ week - CBT                                                                     SWBS                                      6.88±14.8                            3.43±6.67       
    5^th^ week - dietary consulting                                                      Adverse events: NR                                                                             
    6^th^ week - guided imagery                                                                                                                                                         
    7^th^ week - no intervention                                                                                                                                                        
    8^th^ week - no intervention                                                                                                                                                        
  Control group                                                                                                                                                                         
   Approximately 15-min placebo-effect meeting was carried out                                                                                                                          
                                                                                                                                                                                        
  **Author (year)**                                                                      **Exercise intervention**                 **Results**                                          
                                                                                                                                                                                        
  **Outcome measure**                                                                    **Intervention group (after 12 weeks)**   **Control group (after 12 weeks)**                   
                                                                                                                                                                                        
  Gokal *et al*. (2018)\[[@ref11]\]                                                      Intervention group                        Stroop task                          118.93±125.98   177.08±172.71
   12 weeks of home-based walking                                                        WAIS-III                                                                                       
    Begin with completing 10-min walking                                                  Digits backward                          5.21±1.71                            4.88±1.45       
    Gradually increase to 30-min walking                                                  Digits forward                           7.84±1.21                            6.81±1.09       
    Frequency - five times/week                                                          SART                                                                                           
   Recommended guidelines: 150 min of moderate to vigorous physical activity in a week    Errors of omission                       6.56±3.35                            9.08±4.41       
  Control group                                                                           Correct                                  407.59±35.02                         386.22±97.92    
   Usual medical care alone                                                               Incorrect                                357.69±80.38                         353.47±68.22    
                                                                                         CFQ                                       32.48±7.05                           39.20±10.12     
                                                                                         Adverse events: NR                                                                             

USDA: United States Department of Agriculture, BMI: Body mass index, FACT-G: Functional Assessment of Cancer Treatment-General, FACT-B: Functional Assessment of Cancer Treatment-Breast, DB: Diaphragmatic breathing, PMR: Progressive muscle relaxation, CBT: Cognitive behavioral therapy, SRH: Self-reported health, DASS-21: Depression Anxiety Stress Scale-21, HLC: Health locus of control, SWBS: Spiritual Well-Being Scale, WAIS-III: Wechsler Adult Intelligence Scale-III, SART: Sustained Attention to Response Task, CFQ: Cognitive Failures Questionnaire, NR: Nothing reported, →Its plus or minus standard deviation

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

This review yields some major research findings so as to how pedometer-based exercise intervention plays an important role in improving the quality of life in patients with breast cancer who are undergoing chemotherapy. A wide range of studies were identified for the review, but only a few studies on pedometer-based exercises have been done on breast cancer patients undergoing chemotherapy. Pedometer is an inexpensive, portable, and a user-friendly device; therefore, it is very easy to administer in the clinical setup. The use of a pedometer is now gradually taking up the pace. Nevertheless, the studies done till now, using a pedometer, show potential benefits on various health-related parameters during breast cancer survivorship.

The studies retrieved by this review help us to understand that pedometer-based exercises are feasible during the course of chemotherapy in patients with breast cancer. To summarize, the studies included in this review studied the outcome measures such as fatigue, quality of life, body composition, and psychosocial factors in various combinations.

All the three trials selected for the review adopted different protocols using pedometers. Of these, two studies\[[@ref9][@ref11]\] used the ACSM guidelines with regard to the duration of exercise, step counts per day, and the frequency of the exercise.\[[@ref12]\] The other trials\[[@ref10]\] used their own pedometer-based protocols in conjunction with other treatment therapies such as cognitive behavioral therapy and diaphragmatic breathing. The duration of pedometer-based protocols ranged from 8 weeks to 14 weeks. The reason for this variation was cited as the time period required in adapting to the physical activity by patients. Furthermore, the step counts prescribed did not exceed 10,000 which usually is considered normal for a healthy individual.

Various combinations of outcome measures were observed in the three trials. The study conducted by Gokal *et al*. in 2018 has focused more on psychological outcomes. They concluded in their studies that simple physical activity interventions such as walking have a great impact on cognitive functioning, memory, attention, anxiety, fatigue, and depression which in turn has a positive impact on the quality of life. Whereas, the other two studies done by Djuric *et al*., 2011, and Pelekasis *et al*., 2016, have studied the effect of physical activity on body mass index (BMI) and body composition and shown that pedometer-based exercise intervention throughout the course of chemotherapy decreases the skeletal muscle loss and reduces the body fat percentage.

Except for the study by Gokal *et al*., all the other studies had incorporated dietetic intervention or consultation along with the pedometer-based exercise program. Even these studies show positive results on psychological health, BMI, body composition, and other health-related domains of quality of life.

The current review suggests that pedometers have started gaining more importance due to its feasibility when compared to its counterparts such as accelerometers which are much more expensive. Researchers, therefore, have started using it as a physical activity monitor to quantify a walking program. We further suggest that future studies should use the above-mentioned outcomes and design a pedometer-based training for patients with breast cancer to strengthen the current body of evidence in this field of exercise oncology.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

This systematic review concludes that pedometer-based exercise interventions are feasible and beneficial in patients with breast cancer receiving chemotherapy.
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